Thomas M. Deas Jr., MD, practices with Gastroenterology Associates of North Texas and serves as the medical director of Fort Worth (Texas) Endoscopy Center and Southwest Fort Worth Endoscopy Center. He is a fellow of the American College of Gastroenterology…
GI & Endoscopy
Takeda Pharmaceutical and Queen Mary University of London in England announced a major research collaboration that aims to develop new insights and therapies in gastroenterology.
After vying with companies such as Shire and Endo International, it has been announced that Valeant Pharmaceuticals will acquire Salix Pharmaceuticals. Here are five things to know about the acquisition deal, according to an xconomy report.
The FDA released a safety communication in the wake of the outbreak of carbapenem-resistant Enterobacteriaceae linked to duodenoscopes used during ERCP. The statement included recommendations for healthcare providers, patients and reprocessing staff.
Stephen Deal, MD, is a physician with Carolina Digestive Health Associates, which operates five endoscopy centers in the Charlotte, N.C., area. He also serves as the clinical associate professor of medicine at UNC School of Medicine-Charlotte Campus and provides care…
Ferring Pharmaceuticals announced the European launch of CORTIMENTMMX (budesonide) for active mild-to-moderate ulcerative colitis.
Here are seven news updates for gastroenterologists to know for Feb. 20, 2015
Here is a stock report on five publicly traded GI/endoscopy companies for Feb. 13 to Feb. 20.
The patient and physician population is aging. Demand is growing as many in the medical field prepare for retirement. What will happen if a significant physician shortage comes to pass? Four gastroenterologists share their thoughts on how such a shortage…
Duodenoscopes, used during ERCP, have been associated with a number of infections, most recently an outbreak of carbapenem-resistant Enterobacteriaceae at UCLA Ronald Regan Medical Center. The FDA has now released a safety communication focused on duodenoscopes.
